Orbimed Advisors - NEWLINK GENETICS CORP ownership

Quarter-by-quarter ownership
Orbimed Advisors ownership history of NEWLINK GENETICS CORP
ValueSharesWeighting
Q3 2017$8,971,000
-33.9%
881,274
-52.3%
0.09%
-39.4%
Q2 2017$13,568,000
-74.3%
1,846,000
-15.8%
0.14%
-76.3%
Q1 2017$52,820,000
+158.0%
2,191,700
+10.0%
0.60%
+129.5%
Q4 2016$20,475,000
-29.7%
1,991,700
+2.8%
0.26%
-21.4%
Q3 2016$29,113,000
+63.5%
1,938,300
+22.6%
0.33%
+78.5%
Q2 2016$17,808,000
+19.8%
1,581,506
+93.6%
0.19%
+19.2%
Q1 2016$14,870,000
-57.2%
817,006
-14.5%
0.16%
-50.5%
Q4 2015$34,764,000
+36.2%
955,306
+34.1%
0.32%
+22.1%
Q3 2015$25,529,000
-5.4%
712,306
+44.4%
0.26%
+12.2%
Q1 2015$26,988,000
+578.9%
493,300
+393.3%
0.23%
+505.3%
Q4 2014$3,975,000
+85.6%
100,0000.0%0.04%
+72.7%
Q3 2014$2,142,000
-19.3%
100,0000.0%0.02%
-29.0%
Q2 2014$2,655,000100,0000.03%
Other shareholders
NEWLINK GENETICS CORP shareholders Q3 2023
NameSharesValueWeighting ↓
RA Capital Management 1,840,294$34,561,0003.61%
RA Capital Management 500,000$9,390,0000.98%
Knoll Capital Management, LLC 77,437$1,454,0000.78%
WALL STREET ASSOCIATES 349,800$6,569,0000.61%
Montibus Capital Management LLC 251,811$4,729,011,0000.51%
PointState Capital LP 1,000,000$18,780,0000.32%
Prospera Financial Services Inc 40,826$838,0000.32%
TIVERTON ASSET MANAGEMENT LLC 500,000$9,390,0000.23%
BAILARD, INC. 46,000$864,0000.16%
BANKERS TRUST CO 12,277$231,0000.16%
View complete list of NEWLINK GENETICS CORP shareholders